This is a standard proxy filing for an annual shareholder meeting. There are no material financial changes or strategic shifts. Shareholders should review the proxy statement for details on director qualifications and compensation matters, but no significant market impact is expected.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 7 $8.22entry
- T+1 · 7mo ago +13.09%α +10.55% · $9.29
- T+5 · 7mo ago +32.20%α +26.87% · $10.86
- T+20 · 7mo ago −44.37%α −54.15% · $4.57
- T+60 · 5mo ago −43.03%α −56.30% · $4.68
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Passage Bio, Inc. filed a definitive proxy statement for its 2026 Annual Meeting, which includes the election of two Class III directors, ratification of its independent auditor, and approval of executive compensation. This is a routine corporate governance filing.
Key Financial Metrics
Key Facts
- Election of two Class III directors: Athena Countouriotis, M.D. and Sandip Kapadia
- Ratification of KPMG LLP as independent registered public accounting firm for fiscal year 2026
- Approval of executive officer compensation on a non-binding advisory basis
- Approval of frequency for future advisory votes on executive compensation
Financial Impact
Routine corporate governance with no direct financial impact
Risk Factors
- None disclosed in this filing
- Standard risks associated with any biotechnology company
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-040131 |
| Document: 0001104659-26-040131-index-headers.html | 0001104659-26-040131 |
| Document: 0001104659-26-040131-index.html | 0001104659-26-040131 |
| Document: 0001104659-26-040131.txt | 0001104659-26-040131 |
Track record
15 reports on PASG
2 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +22.24% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 6, 202610d ago 8-K Neutral 5/10 Entry $3.98 Now $4.13 +3.90% settles Dec 7
- Oct 13, 20265w ago EFFECT Neutral 3/10 Entry $3.64 to $3.78 Now $4.13 +13.46% ▲ +3.85% +7.46% vs SPY
- Oct 8, 20265w ago S-4/A Bearish 6/10 Entry $3.69 to $3.98 Now $4.13 −11.92% ▼ −7.72% −13.28% vs SPY
- Oct 5, 20266w ago S-4/A Neutral 5/10 Entry $4.08 to $3.41 Now $4.13 +1.23% ▼ −16.47% −13.56% vs SPY
- Sep 21, 20268w ago S-4/A Neutral 5/10 Entry $4.95 to $3.60 Now $4.13 −16.57% ▼ −27.27% −26.71% vs SPY
- Sep 2, 202610w ago S-4/A / 425 Bearish 8/10 Entry $4.75 to $4.12 Now $4.13 +13.05% ▲ +13.26% +12.08% vs SPY
- Sep 2, 202610w ago 8-K Bullish 8/10 Entry $4.75 to $4.12 Now $4.13 −13.05% ▼ −13.26% −12.08% vs SPY
- Jun 24, 202620w ago 425 Bearish 7/10 Entry $4.33 to $4.90 Now $4.13 +4.62% ▼ −13.16% −12.64% vs SPY
- Jun 24, 202620w ago 425 Bearish 7/10 Entry $4.33 to $4.90 Now $4.13 +4.62% ▼ −13.16% −12.64% vs SPY
- Jun 24, 202620w ago 8-K Bearish 7/10 Entry $4.33 to $4.90 Now $4.13 +4.62% ▼ −13.16% −12.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers